Megan Hardin

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 3

Top Topics

Replacement Therapy

Atopic Dermatitis

Top Venues

Journal of asthma and allergy

This page only lists publications with an associated author ORCID identifier.

Publications

Njira L Lugogo, Enrico Heffler, Vicente Plaza Moral, Ole Hilberg, Changming Xia, Scott Nash, Nami Pandit, Juby Anne Jacob-Nara, Harry J Sacks, Paul J Rowe, Yamo Deniz, Megan Hardin, Xavier Soler
Baseline Systemic Oral Corticosteroid Use in Patients with Asthma Initiating Dupilumab Treatment in the Real World: From the RAPID Global Registry. Journal of asthma and allergy 17 (2024)
Njira L Lugogo, Enrico Heffler, Vicente Plaza Moral, Ole Hilberg, Changming Xia, Scott Nash, Nami Pandit, Juby Anne Jacob-Nara, Harry J Sacks, Paul J Rowe, Yamo Deniz, Megan Hardin, Xavier Soler
Baseline Systemic Oral Corticosteroid Use in Patients with Asthma Initiating Dupilumab Treatment in the Real World: From the RAPID Global Registry. Journal of asthma and allergy 17 (2024)
Ian Douglas Pavord, Arnaud Bourdin, Alberto Papi, Christian Domingo Ribas, Jonathan Corren, Arman Altincatal, Amr Radwan, Nami Pandit, Juby Anne Jacob-Nara, Yamo Deniz, Paul J Rowe, Elizabeth Laws, David J Lederer, Megan Hardin
Dupilumab sustains efficacy in patients with moderate-to-severe type 2 asthma regardless of ICS dose. Allergy (2023)